EXACT Therapeutics AS

OB:EXTX 株式レポート

時価総額：NOK 182.9m

EXACT Therapeutics マネジメント

マネジメント 基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Per Walday

最高経営責任者

NOK 2.8m

報酬総額

CEO給与比率80.2%
CEO在任期間2.4yrs
CEOの所有権n/a
経営陣の平均在職期間2.3yrs
取締役会の平均在任期間5.1yrs

経営陣の近況

Recent updates

Here's Why We're Watching EXACT Therapeutics' (OB:EXTX) Cash Burn Situation

Aug 09
Here's Why We're Watching EXACT Therapeutics' (OB:EXTX) Cash Burn Situation

Is EXACT Therapeutics (OB:EXTX) In A Good Position To Invest In Growth?

Apr 20
Is EXACT Therapeutics (OB:EXTX) In A Good Position To Invest In Growth?

We Think EXACT Therapeutics (OB:EXTX) Can Afford To Drive Business Growth

Sep 07
We Think EXACT Therapeutics (OB:EXTX) Can Afford To Drive Business Growth

We're Hopeful That EXACT Therapeutics (OB:EXTX) Will Use Its Cash Wisely

May 06
We're Hopeful That EXACT Therapeutics (OB:EXTX) Will Use Its Cash Wisely

Here's Why We're Watching EXACT Therapeutics' (OB:EXTX) Cash Burn Situation

Dec 30
Here's Why We're Watching EXACT Therapeutics' (OB:EXTX) Cash Burn Situation

Companies Like EXACT Therapeutics (OB:EXTX) Are In A Position To Invest In Growth

Sep 15
Companies Like EXACT Therapeutics (OB:EXTX) Are In A Position To Invest In Growth

EXACT Therapeutics (OB:EXTX) Is In A Good Position To Deliver On Growth Plans

Jan 31
EXACT Therapeutics (OB:EXTX) Is In A Good Position To Deliver On Growth Plans

We Think EXACT Therapeutics (OB:EXTX) Can Afford To Drive Business Growth

Aug 21
We Think EXACT Therapeutics (OB:EXTX) Can Afford To Drive Business Growth

We're Not Very Worried About EXACT Therapeutics' (OB:EXTX) Cash Burn Rate

May 21
We're Not Very Worried About EXACT Therapeutics' (OB:EXTX) Cash Burn Rate

CEO報酬分析

EXACT Therapeutics の収益と比較して、Per Walday の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

-NOK 55m

Mar 31 2024n/an/a

-NOK 52m

Dec 31 2023NOK 3mNOK 2m

-NOK 48m

Sep 30 2023n/an/a

-NOK 42m

Jun 30 2023n/an/a

-NOK 36m

Mar 31 2023n/an/a

-NOK 38m

Dec 31 2022NOK 2mNOK 1m

-NOK 40m

報酬と市場: Perの 総報酬 ($USD 255.78K ) は、 Norwegian市場 ($USD 300.00K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Perの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Per Walday (64 yo)

2.4yrs

在職期間

NOK 2,833,302

報酬

Dr. Per Walday, Ph D., has been the Chief Executive Officer at PCI Biotech AS since 2008. He serves as Chief Executive Officer at EXACT Therapeutics AS since June 5, 2022.Dr. Walday had been the Chief Exe...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Per Walday
Chief Executive Officer2.4yrsNOK 2.83mデータなし
Masha Paule Nathalie Stromme
Vice-Chair of the Board9.8yrsNOK 445.00kデータなし
Svein Kvåle
Co Founder & COOno dataNOK 1.65m9.43%
NOK 17.2m
John Edminson
Chief Financial Officer2.1yrsNOK 2.02mデータなし
Amir Snapir
Chief Medical Officer2.2yrsNOK 2.66mデータなし
Caspar Foghsgaard
Chief Business Officerless than a yearNOK 250.00kデータなし
Per Sontum
Founderno dataNOK 2.49m5.99%
NOK 11.0m
Ragnar Bendicksen
Vice President of Technology2.6yrsデータなしデータなし

2.3yrs

平均在職期間

経験豊富な経営陣: EXTXの経営陣は 経験豊富 であると考えられます ( 2.3年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Masha Paule Nathalie Stromme
Vice-Chair of the Board9.8yrsNOK 445.00kデータなし
William Castell
Director6.8yrsNOK 275.00k1.05%
NOK 1.9m
Anders Wold
Chair of the Board2.9yrsNOK 510.00kデータなし
Ann-Tove Kongsnes
Director3.4yrsNOK 260.00kデータなし

5.1yrs

平均在職期間

経験豊富なボード: EXTXの 取締役会 は 経験豊富 であると考えられます ( 5.1年の平均在任期間)。